BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

  1. Homepage
  2. Medicinal products
  3. Pharmacovigilance
  4. Risk information

Information letter on Etopophos® 100-/1000 mg (etoposide): Shortage and procedure for ordering

2016.07.14

Active substance: etoposide

The company Bristol-Myers Squibb GmbH & Co. KGaA is circulating information regarding the shortage of Etopophos® 100-/1000 mg.

Download DHPC/Information letter , Download_VeroeffentlichtAm_EN PDF, 146KB, File is accessible